Jean-Philippe Michel
Overview
Explore the profile of Jean-Philippe Michel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chapron D, Michel J, Fontaine P, Godard J, Bregier F, Sol V, et al.
Colloids Surf B Biointerfaces
. 2023 Oct;
231:113565.
PMID: 37778109
The photosensitizer Phenalenone (PN) was grafted with one or two lipid (C) chains to form pure nano-assemblies or mixed lipid vesicles suitable for photodynamic therapy. Mixtures of PN-C conjugates with...
2.
Medard J, Sun X, Pinson J, Li D, Mangeney C, Michel J
Langmuir
. 2021 Oct;
37(43):12539-12547.
PMID: 34677986
We present two different molecular organizations obtained from octadecylamine (ODA) molecules on a highly oriented pyrolytic graphite (HOPG) surface: (i) self-organized physisorbed ODA molecules lying flat on the surface and...
3.
Diaz-Salmeron R, Da Costa A, Michel J, Ponchel G, Bouchemal K
Int J Pharm
. 2021 Oct;
609:121172.
PMID: 34627996
Drug delivery to target sites is often limited by inefficient particle transport through biological media. Herein, motion behaviors of spherical and nonspherical nanomaterials composed of hyaluronic acid were studied in...
4.
Coppens E, Desmaele D, Naret T, Garcia-Argote S, Feuillastre S, Pieters G, et al.
Int J Pharm
. 2021 Sep;
609:121076.
PMID: 34481886
A simple approach to achieve a lipoprotein (LP)-mediated drug delivery is to trigger the spontaneous drug insertion into endogenous lipoproteins in the bloodstream, by means of its chemical modification. Nanoparticles...
5.
Diaz-Salmeron R, Michel J, Hadji H, Gout E, Vives R, Ponchel G, et al.
Colloids Surf B Biointerfaces
. 2021 Jun;
205:111916.
PMID: 34146785
Increasing valence by acting on nanomaterial morphology can enhance the ability of a ligand to specifically bind to targeted cells. Herein, we investigated cell internalization of soft hyaluronic acid (HA)...
6.
Liu Z, Raj S, van Rhijn N, Fraczek M, Michel J, Sismeiro O, et al.
mBio
. 2021 May;
12(3).
PMID: 34006660
Inhibition of fungal growth by Congo red (CR) has been putatively associated with specific binding to β-1,3-glucans, which blocks cell wall polysaccharide synthesis. In this study, we searched for transcription...
7.
Zmerli I, Michel J, Makky A
J Mater Chem B
. 2020 May;
8(20):4489-4504.
PMID: 32365146
Polydopamine (PDA) is a bioinspired fascinating polymer which is considered nowadays as a material of choice for designing drug delivery nanosystems. Indeed, PDA exhibits multiple interesting features including simple preparation...
8.
Mougin J, Yesylevskyy S, Bourgaux C, Chapron D, Michel J, Dosio F, et al.
ACS Nano
. 2019 Oct;
13(11):12870-12879.
PMID: 31603305
The development of elongated nanoparticles for drug delivery is of growing interest in recent years, due to longer blood circulation and improved efficacy compared to spherical counterparts. Squalenoyl-doxorubicin (SQ-Dox) conjugate...
9.
Rouquette M, Ser-Le Roux K, Polrot M, Bourgaux C, Michel J, Testard F, et al.
J Drug Target
. 2019 Feb;
27(5-6):699-708.
PMID: 30786788
Squalene-adenosine (SQAd) nanoparticles (NPs) were found to display promising pharmacological activity similar to many other nanomedicines, but their long-term stability was still limited, and their preparation required specific know-how and...
10.
NDiaye M, Michel J, Rosilio V
Phys Chem Chem Phys
. 2019 Feb;
21(8):4306-4319.
PMID: 30724271
In specific conditions, co-incubation of polymer nanoparticles and phospholipid vesicles leads to the formation of lipid bilayer coated nanoparticles usable as biocompatible drug delivery systems for co-encapsulation of two drugs....